Life-threatening motor neurotoxicity in association with bortezomib
- PMID: 16757419
Life-threatening motor neurotoxicity in association with bortezomib
Abstract
Bortezomib has been licensed to be used in relapsed and refractory multiple myeloma. It is a promising agent for this incurable condition but our effort is to caution hematologists about the life-threatening neurotoxicity (grade 4) which was seen in two of six patients treated with this agent although the complication cannot definitely be attributed to bortezomib.
Comment in
-
Perspective on the current use of bortezomib in multiple myeloma.Haematologica. 2006 Jul;91(7):871-2. Haematologica. 2006. PMID: 16818272 No abstract available.